Back
Galectin Therapeutics Inc. GALT · Insights
Galectin Therapeutics Inc. is a biopharmaceutical company in the clinical development phase, dedicat... Price3.46
Market Cap348.94 M
Float54.27 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro